Filing exhibits
- 8-K Current report
- 3.1 Certificate of Designations of Preferences and Rights of Series B Convertible Preferred Stock
- 4.1 Warrant
- 10.1 Securities Purchase Agreement
- 10.2 Registration Rights Agreement
- 10.3 Agreement
- 99.1 PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000
- Download Excel data file
- View Excel data file
Table of Contents